KR20220067979A - Composition for improving memory and learning ability including natural plant extract - Google Patents
Composition for improving memory and learning ability including natural plant extract Download PDFInfo
- Publication number
- KR20220067979A KR20220067979A KR1020200154817A KR20200154817A KR20220067979A KR 20220067979 A KR20220067979 A KR 20220067979A KR 1020200154817 A KR1020200154817 A KR 1020200154817A KR 20200154817 A KR20200154817 A KR 20200154817A KR 20220067979 A KR20220067979 A KR 20220067979A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- memory
- cognitive function
- improving memory
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 230000015654 memory Effects 0.000 title claims abstract description 32
- 230000013016 learning Effects 0.000 title claims abstract description 22
- 239000000419 plant extract Substances 0.000 title description 2
- 239000000284 extract Substances 0.000 claims abstract description 110
- 230000003920 cognitive function Effects 0.000 claims abstract description 35
- 230000006386 memory function Effects 0.000 claims description 28
- 235000013305 food Nutrition 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 235000020729 noni extract Nutrition 0.000 claims description 7
- 240000002853 Nelumbo nucifera Species 0.000 claims description 6
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 6
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 230000000302 ischemic effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 40
- 230000001965 increasing effect Effects 0.000 abstract description 6
- 230000003013 cytotoxicity Effects 0.000 abstract description 4
- 231100000135 cytotoxicity Toxicity 0.000 abstract description 4
- 229930014626 natural product Natural products 0.000 abstract description 4
- 235000004478 Tragopogon dubius Nutrition 0.000 abstract 2
- 235000012363 Tragopogon porrifolius Nutrition 0.000 abstract 2
- 240000006060 Tragopogon pratensis Species 0.000 abstract 2
- 235000013376 functional food Nutrition 0.000 description 18
- 230000036541 health Effects 0.000 description 16
- 239000000796 flavoring agent Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 9
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 8
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 235000019629 palatability Nutrition 0.000 description 8
- 235000013361 beverage Nutrition 0.000 description 7
- 210000002569 neuron Anatomy 0.000 description 7
- 102100033639 Acetylcholinesterase Human genes 0.000 description 6
- 108010022752 Acetylcholinesterase Proteins 0.000 description 6
- 108010057466 NF-kappa B Proteins 0.000 description 6
- 102000003945 NF-kappa B Human genes 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 235000020237 cranberry extract Nutrition 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 235000020737 peppermint extract Nutrition 0.000 description 6
- 235000008422 Schisandra chinensis Nutrition 0.000 description 5
- 240000006079 Schisandra chinensis Species 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- 241001444063 Aronia Species 0.000 description 4
- 235000021537 Beetroot Nutrition 0.000 description 4
- 235000005979 Citrus limon Nutrition 0.000 description 4
- 244000131522 Citrus pyriformis Species 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 235000016623 Fragaria vesca Nutrition 0.000 description 4
- 240000009088 Fragaria x ananassa Species 0.000 description 4
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 235000010676 Ocimum basilicum Nutrition 0.000 description 4
- 240000007926 Ocimum gratissimum Species 0.000 description 4
- 240000000377 Tussilago farfara Species 0.000 description 4
- 235000004869 Tussilago farfara Nutrition 0.000 description 4
- 229940064008 acai berry extract Drugs 0.000 description 4
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 4
- 229960004373 acetylcholine Drugs 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229940055416 blueberry extract Drugs 0.000 description 4
- 235000019216 blueberry extract Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 229940065115 grapefruit extract Drugs 0.000 description 4
- 229940083980 lavender extract Drugs 0.000 description 4
- 235000020723 lavender extract Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000004770 neurodegeneration Effects 0.000 description 4
- 230000004766 neurogenesis Effects 0.000 description 4
- 229940117336 parsley extract Drugs 0.000 description 4
- 229940112950 sage extract Drugs 0.000 description 4
- 235000020752 sage extract Nutrition 0.000 description 4
- 230000002103 transcriptional effect Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000007787 long-term memory Effects 0.000 description 3
- 230000007087 memory ability Effects 0.000 description 3
- 206010027175 memory impairment Diseases 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 235000015277 pork Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000020991 processed meat Nutrition 0.000 description 3
- 235000021067 refined food Nutrition 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- AAXWBCKQYLBQKY-IRXDYDNUSA-N (2s)-2-[[(2s)-2-[(2-benzamidoacetyl)amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-4-methylpentanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)C=1C=CC=CC=1)C1=CN=CN1 AAXWBCKQYLBQKY-IRXDYDNUSA-N 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 235000011330 Armoracia rusticana Nutrition 0.000 description 2
- 240000003291 Armoracia rusticana Species 0.000 description 2
- 230000005778 DNA damage Effects 0.000 description 2
- 231100000277 DNA damage Toxicity 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- 208000026139 Memory disease Diseases 0.000 description 2
- 208000007256 Nevus Diseases 0.000 description 2
- 241000208317 Petroselinum Species 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 229940022698 acetylcholinesterase Drugs 0.000 description 2
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 230000007177 brain activity Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 229940105922 elm extract Drugs 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 description 2
- 231100000304 hepatotoxicity Toxicity 0.000 description 2
- 210000001320 hippocampus Anatomy 0.000 description 2
- 108010016268 hippuryl-histidyl-leucine Proteins 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000006984 memory degeneration Effects 0.000 description 2
- 208000023060 memory loss Diseases 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- -1 pH adjusters Substances 0.000 description 2
- 235000011197 perejil Nutrition 0.000 description 2
- 235000013324 preserved food Nutrition 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000006403 short-term memory Effects 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SMBBQHHYSLHDHF-UHFFFAOYSA-M 2-acetyloxyethyl(trimethyl)azanium;iodide Chemical compound [I-].CC(=O)OCC[N+](C)(C)C SMBBQHHYSLHDHF-UHFFFAOYSA-M 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 241000745768 Pluchea carolinensis Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 229940039856 aricept Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000012813 breadcrumbs Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012916 chromogenic reagent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229960003530 donepezil Drugs 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229960003980 galantamine Drugs 0.000 description 1
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 230000000971 hippocampal effect Effects 0.000 description 1
- 230000009808 hippocampal neurogenesis Effects 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 210000003140 lateral ventricle Anatomy 0.000 description 1
- 230000028252 learning or memory Effects 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000003695 memory enhancer Substances 0.000 description 1
- 230000006883 memory enhancing effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000019992 sake Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 235000020083 shōchū Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 230000006886 spatial memory Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 229960001685 tacrine Drugs 0.000 description 1
- YLJREFDVOIBQDA-UHFFFAOYSA-N tacrine Chemical compound C1=CC=C2C(N)=C(CCCC3)C3=NC2=C1 YLJREFDVOIBQDA-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 235000019511 tuna Nutrition 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- 230000003936 working memory Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/23—Removal of unwanted matter, e.g. deodorisation or detoxification by extraction with solvents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 눈개승마 추출물을 포함하는 기억력 개선 및 학습능력 개선용 조성물에 관한 것이다. 보다 상세하게 본 발명은 기억력 및 인지기능 개선 활성을 높이고, 집중력 및 학습능력을 증진시킬 수 있는 천연물 기반의 조성물을 제공하기 위한 것이다. 특히 상기 눈개승마의 새로운 용도를 제공함으로서 상기 눈개승마에 대한 새로운 수요처를 발굴할 수 있도록 하기 위한 것이다.The present invention relates to a composition for improving memory and learning ability, comprising an extract of nipae equestrian horse. In more detail, the present invention is to provide a composition based on a natural product that can increase memory and cognitive function improvement activity, and enhance concentration and learning ability. In particular, by providing a new use of the snow-riding, it is to discover a new demand for the snow-riding horse.
현대인들은 사회적 환경이 급격하고 다양하게 변화함에 따라 과거에 비해 점점 더 많은 자극을 접하게 되고 이를 수용하기 위한 신속한 두뇌활동이 요구된다. 청소년, 특히 수험생들의 장기간 학습 활동 내지 기억 활동은 심신을 비롯하여 두뇌의 피로를 유발하며 두뇌의 건전한 발달에도 영향을 미칠 수 있다. 중년기 이후에는 중추신경의 기능저하로 인한 기억력감퇴 또는 건망증 등의 증상이 나타날 수 있으며, 노인층에서는 치매와 같은 퇴행성 뇌질환에 의해 기억능력이 저하되어 그 정도가 심한 경우 사회생활 자체를 불가능하게 되고 가족이나 주변사람들에 미치는 영향을 고려한다면 엄청난 사회적 비용이 요구될 수 있다.As the social environment changes rapidly and diversely, modern people encounter more and more stimuli than in the past, and rapid brain activity is required to accommodate them. Adolescents, especially long-term learning or memory activities, cause mental and physical fatigue of the brain and may affect the healthy development of the brain. After middle age, symptoms such as memory loss or forgetfulness due to central nervous system dysfunction may appear. However, considering the impact on the people around them, a huge social cost can be required.
신경발생(neurogenesis)은 NPC(Neuronal precursor cell)로부터 뉴론이 생성되는 과정이다. 성체 포유류의 뇌신경세포는 그 수가 한정되어 있으며, 발생기 이후에는 새로운 신경세포가 생성되지 않는다고 여겨져 왔다. 그러나 많은 연구들에 의하면 측뇌실의 부뇌실 구역(SVZ)과 해마 치상회(hippocampal denatate gyrus)의 과립화 구역(SGZ)에서 성년동안 지속적으로 신경발생, 즉 뉴론의 생성 및 분화가 일어남이 밝혀지고 있다. 성인 해마에서의 신경발생은 인지기능의 조절과 관련이 있다. 해마의 NPC에 의해 유도된 신생 뉴론은 사물 인식 기억 뿐 아니라 장기 및 단기 공간 기억에 주요한 역할을 하고 있음을 지지하는 증거들이 증가하고 있다. 심리학에서의 기억은 학습에 의한 변화가 오래 지속되는 것을 의미하여 학습과 기억은 서로 불가분의 관계에 있으며, 학습의 결과는 기억의 양과 질을 통해 측정된다. 따라서 NPC의 자극에 의한 해마의 신경발생 증가는 학습 및 기억을 포함한 인지기능을 증가시키는 실현가능한 전략으로 여겨진다.Neurogenesis (neurogenesis) is a process in which neurons are generated from NPCs (Neuronal precursor cells). It has been believed that the number of brain neurons in adult mammals is limited, and that no new neurons are generated after the developmental stage. However, many studies have revealed that neurogenesis, that is, the generation and differentiation of neurons, occurs continuously during adulthood in the subventricular zone (SVZ) of the lateral ventricle and the granulation zone (SGZ) of the hippocampal denatate gyrus. . Neurogenesis in the adult hippocampus is associated with the regulation of cognitive function. There is growing evidence supporting that new neurons induced by NPCs in the hippocampus play a major role in long-term and short-term spatial memory as well as object recognition memory. In psychology, memory means that changes caused by learning last a long time, so learning and memory are inseparable from each other, and the result of learning is measured through the quantity and quality of memory. Therefore, increase in hippocampal neurogenesis by NPC stimulation is considered a feasible strategy to increase cognitive functions including learning and memory.
노령 인구의 증가에 따라 인지기능의 향상을 위한 연구들은 퇴행성 신경질환에 의한 신경변성을 치료하는 질병치료의 면에서 주로 접근되어 왔다. 신경변성은 중추 신경계의 신경세포가 이상 단백질 응집체의 축적에 따라 변성이 일어나 기능부전이나 세포사에 빠지게 되는 진행성 질환으로, 이의 치료를 위해서는 이상 단백질 응집체의 형성을 억제하는 것을 타겟으로 한다.As the aging population increases, studies for improving cognitive function have been mainly approached in terms of disease treatment to treat neurodegeneration caused by neurodegenerative diseases. Neurodegeneration is a progressive disease in which neuronal cells of the central nervous system are degenerated according to the accumulation of abnormal protein aggregates and fall into dysfunction or cell death.
그러나 질환적인 측면 뿐만 아니라 신경변성과 같은 질병이 없는 일반인의 경우에도 사회적인 환경의 다변화에 따라 현대 사회를 살아가기 위해서는 많은 자극을 수용하기 위한 신속한 두뇌활동이 요구된다. 학습능력은 지적활동 능력과 직접적인 연관을 가진 것으로 궁극적으로는 삶의 질에 영향을 미친다. 또한, 선천적으로 기억력과 관련된 지적능력이 낮아 학업능력이 떨어지는 학습지진아에 대해서 현대의학에서는 기억력 향상제로 콜린에스터레이즈 억제제를 사용하고 있으나, 현기증, 떨림증, 구토, 간 독성과 같은 부작용이 너무 심해 일부 효과에도 불구하고 그 적용에 제한이 있다. 더구나 입시경쟁이 치열해짐에 따라 장기간 학습활동이 필수적인 수험생에게는 기억력 증진 및 학습능력 향상에 효과가 있다는 '보약'은 물론, 단기적인 집중력 향상을 위하여 주의력 결핍 과잉행동장애의 치료제로 쓰이는 약물이 소위 '공부 잘하는 약'으로 남용되기도 한다. 이에 보다 안전하게 사용될 수 있는 기억력 및 학습능력 증진을 위한 조성물이 요구되어 진다.However, rapid brain activity is required to accommodate many stimuli in order to live in modern society according to the diversification of social environments even in the case of ordinary people without diseases such as neurodegeneration as well as disease aspects. Learning ability is directly related to intellectual activity ability and ultimately affects quality of life. In addition, modern medicine uses cholinesterase inhibitors as a memory enhancer for children with learning earthquake who have poor academic ability due to congenitally low intellectual ability related to memory, but some effects such as dizziness, tremor, vomiting and liver toxicity are too severe. Nevertheless, its application is limited. Moreover, as the competition for entrance exams intensifies, for students who need long-term learning activities, not only 'remedies' that are effective in improving memory and learning ability, but also drugs used as a treatment for attention deficit hyperactivity disorder to improve short-term concentration are so-called 'studying'. It is also abused as a ‘good drug’. Accordingly, there is a need for a composition for enhancing memory and learning ability that can be used more safely.
기억은 의식적 또는 무의식적인 상태에서 과거의 일을 생각해내는 능력을 말하는데, 특히 학습과 기억은 상호 밀접하게 연관되어 있어 항상 동시에 고려되어야 한다. 기억은 기술의 습득, 습관 등이 포함되는 무의식적인 비서술성 기억(nondeclarative memory)과 과거에 일어났던 사실이나 사건과 같이 의식적으로 재생이 가능한 서술성 기억(declarative memory)으로 나눌 수 있다. 그러나, 운전이나 피아노를 치는 것과 같은 복잡한 행동도 습관화 되면 무의식적으로 행할 수 있듯이 반복에 의하여 서술성 기억이 비서술성 기억으로 전환될 수 있다.Memory refers to the ability to recall events in the past, either consciously or unconsciously. Memory can be divided into unconscious nondeclarative memory, which includes the acquisition of skills and habits, and declarative memory, which can be consciously reproduced, such as facts or events that occurred in the past. However, as complex behaviors such as driving or playing the piano can be performed unconsciously when habituated, narrative memory can be converted into non-narrative memory by repetition.
서술성 기억은 현재 주어지는 정보에 집중하고 수초 동안만 임시로 저장하는 작업기억(working memory), 수시간 내지 수일간 기억이 지속되는 단기기억(short-term memory), 오랜 시간이 지난 과거의 일을 기억하는 장기기억(remote memory) 등으로 구분된다. 단기기억은 현재 진행되고 있는 사건에 대한 기억이 장기기억으로 전환되는 기간을 포함한다. 이 기간 동안 기억으로서의 저장이 취약하여 망각되기 쉬우나, 일단 장기기억으로 저장되면 뇌에 심각한 손상이 있는 경우에도 쉽게 잊어버리지 않는다.Descriptive memory consists of working memory, which focuses on present information and stores it temporarily for only a few seconds, short-term memory, which lasts for hours to days, and It is divided into long-term memory (remote memory), etc. Short-term memory includes the period during which memories of ongoing events are converted into long-term memory. During this period, storage as memory is weak and easily forgotten, but once stored in long-term memory, it is not easily forgotten even if there is serious damage to the brain.
기억은 세 가지 단계로 이루어질 수 있는데, 첫 번째로 새로운 정보 또는 지식을 외워서 뇌에 입력하는 입력단계, 두 번째는 상기 뇌에 입력된 정보 또는 지식을 뇌에 저장하는 저장단계, 세 번째는 상기 저장된 정보 또는 지식을 다시 생각하는 회상단계가 그것이다. 상기 세 단계 중에 어느 하나라도 이상이 생기면 정보 또는 지식을 정확하게 기억할 수 없게 되는 현상 즉, 기억력 저하 내지 감퇴가 일어날 수 있다.Memory can be made up of three stages. First, the input stage of memorizing new information or knowledge and inputting it into the brain, the second storing stage of storing the information or knowledge inputted into the brain in the brain, and the third storing the stored information. This is the recall phase, in which information or knowledge is reconsidered. If any one of the above three steps is abnormal, a phenomenon in which information or knowledge cannot be accurately remembered, that is, memory deterioration or decline may occur.
상기 기억력의 저하 내지 감퇴는 뇌조직의 신경세포에서 아세틸콜린에스터라제의 작용으로 인한 아세틸콜린의 양의 감소, β-amyloid(βA) 등으로 유발된 신경독성 등의 다양한 원인으로 인한 뇌세포의 괴사가 원인인 것으로 알려져 있다.The decrease or decline of the memory is caused by various causes, such as a decrease in the amount of acetylcholine due to the action of acetylcholinesterase in neurons of brain tissue, and neurotoxicity caused by β-amyloid (βA). Necrosis is known to be the cause.
이에 기억능력의 저하 내지 감퇴에 대하여 현재 외과적 방법이나 약물적 방법이 모두 사용되고 있으나, 외과적 방법은 용이하지 아니한 측면이 있어 약물적 방법이 권장되고 있다. 상기 약물적 방법으로서 아세틸콜린을 분해하는 효소인 아세틸콜린에스터라제의 활성억제제(타크린, 아리셉트, 도네페질, 리바스티그린 또는 갈란타민 등)가 상업화되어 있으나, 이는 기억능력의 저하 내지 감퇴를 치료하기 보다는 신경전달물질을 조절하여 일시적 증상 호전을 나타낼 뿐이다. 더군다나 간독성, 위장관장애, 심장 서맥 유발, 체중감소 및 불면증 등의 부작용과 장기복용에 따른 독성 내지 의존성이 문제점으로 지적되고 있어 이를 보완하기 위한 새로운 제품들에 대한 개발이 요구되고 있다.For this reason, both surgical and pharmacological methods are currently used for the deterioration or decline of memory ability, but the surgical method is not easy, so the pharmacological method is recommended. As the above pharmacological method, inhibitors of the activity of acetylcholinesterase, an enzyme that decomposes acetylcholine (tacrine, aricept, donepezil, rivastigrin or galantamine, etc.), are commercially available, but they do not reduce or decrease memory ability. Rather than treating it, it only shows temporary symptom improvement by regulating neurotransmitters. Moreover, side effects such as hepatotoxicity, gastrointestinal disorders, cardiac bradycardia, weight loss and insomnia, and toxicity or dependence due to long-term use are pointed out as problems, and the development of new products is required to compensate for these problems.
본 발명의 목적은 천연물을 기반으로 한 기억력 및 인지기능 개선효과를 가지는 눈개승마 추출물을 포함하는 조성물을 제공하기 위한 것이다.It is an object of the present invention to provide a composition comprising an extract of nipae equestrian horse having an effect of improving memory and cognitive function based on a natural product.
본 발명에 따른 눈개승마 추출물을 포함하는 조성물은 천연 추출물로서, 세포독성 등의 부작용의 문제가 없어 장기간 사용하면서, 기억력 및 인지기능 개선하고 학습능력을 증진할 수 있는 효과를 달성할 수 있도록 하기 위한 것이다.The composition comprising the extract of nipae equestrian according to the present invention is a natural extract, and there is no problem of side effects such as cytotoxicity, so that it can be used for a long period of time to achieve the effect of improving memory and cognitive function and enhancing learning ability will be.
본 발명의 목적은 눈개승마 추출물을 포함하는 기억력 및 인지기능 개선할 수 있는 다양한 제형의 식품 또는 건강기능식품을 제공하기 위한 것이다. It is an object of the present invention to provide a food or health functional food of various formulations capable of improving memory and cognitive function, including the extract of nipae equestrian horse.
본 발명의 목적은 상기 눈개승마에 대한 새로운 용도를 제시하고, 이를 통하여 다양한 기능성 제품으로 상품화 됨으로서, 상기 눈개승마에 대한 새로운 수요가 발굴될 수 있도록 하기 위한 것이다.An object of the present invention is to suggest a new use for the snow horse riding, and through this, it is commercialized as a variety of functional products, so that a new demand for the snow horse riding can be discovered.
상기 목적을 달성하기 위하여, 본 발명의 일 실시예에 따른 기억력 및 인지기능 개선용 조성물은 눈개승마 추출물을 포함하는 것이다.In order to achieve the above object, the composition for improving memory and cognitive function according to an embodiment of the present invention is to include an extract of nipae equestrian horse.
상기 추출물은 물, 탄소수 1 내지 10의 알코올 및 이들의 혼합물로 이루어진 군에서 선택된 어느 하나를 용매로 추출된 것일 수 있다.The extract may be one selected from the group consisting of water, alcohols having 1 to 10 carbon atoms, and mixtures thereof with a solvent.
상기 기억력 및 인지기능 개선용 조성물은 연꽃 추출물 또는 두릅 추출물을 더 포함하는 것일 수 있다.The composition for improving memory and cognitive function may further include a lotus flower extract or an oleifera extract.
상기 기억력 및 인지기능 개선용 조성물은 노니 추출물을 더 포함하는 것일 수 있다.The composition for improving memory and cognitive function may further include a noni extract.
본 발명의 다른 일 실시예에 따른 기억력 개선 및 학습능력 증진용 식품은 상기 조성물을 포함하는 것일 수 있다.Food for improving memory and learning ability according to another embodiment of the present invention may include the composition.
상기 식품은 오미자 추출물, 딸기 추출물, 아사이베리 추출물, 아로니아 추출물, 블루베리 추출물, 크랜베리 추출물, 자몽 추출물, 오렌지 추출물, 레몬 추출물, 초코민트 추출물, 바질 추출물, 페퍼민트 추출물, 세이지 추출물, 라벤더 추출물, 파슬리 추출물, 곰피 추출물, 방풍나물 추출물, 머위 추출물, 달래 추출물 및 이들의 혼합으로 이루어진 군에서 선택된 어느 하나를 더 포함하는 것일 수 있다.The food is Schisandra extract, strawberry extract, acai berry extract, aronia extract, blueberry extract, cranberry extract, grapefruit extract, orange extract, lemon extract, chocomint extract, basil extract, peppermint extract, sage extract, lavender extract, parsley It may be to further include any one selected from the group consisting of extracts, gompi extract, beetroot extract, coltsfoot extract, soothing extract, and mixtures thereof.
본 발명의 또 다른 일 실시예에 따른 기억력 개선 및 학습능력 증진용 건강기능식품은 상기 조성물을 포함하는 것일 수 있다.A health functional food for improving memory and learning ability according to another embodiment of the present invention may include the composition.
상기 건강기능식품은 오미자 추출물, 딸기 추출물, 아사이베리 추출물, 아로니아 추출물, 블루베리 추출물, 크랜베리 추출물, 자몽 추출물, 오렌지 추출물, 레몬 추출물, 초코민트 추출물, 바질 추출물, 페퍼민트 추출물, 세이지 추출물, 라벤더 추출물, 파슬리 추출물, 곰피 추출물, 방풍나물 추출물, 머위 추출물, 달래 추출물 및 이들의 혼합으로 이루어진 군에서 선택된 어느 하나를 더 포함하는 것일 수 있다.The health functional food is Schisandra extract, strawberry extract, acai berry extract, aronia extract, blueberry extract, cranberry extract, grapefruit extract, orange extract, lemon extract, chocomint extract, basil extract, peppermint extract, sage extract, lavender extract , parsley extract, gompi extract, beetroot extract, coltsfoot extract, soothing extract, and any one selected from the group consisting of a mixture thereof may be further included.
이하, 본 발명을 더욱 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명의 일 실시예에 따른 기억력 및 인지기능 개선용 조성물은 눈개승마 추출물을 포함하는 것이다.The composition for improving memory and cognitive function according to an embodiment of the present invention is to include an extract of nipae equestrian horse.
상기 눈개승마는 전국 각처의 고산지역에서 자라는 다년생 초본이다. 생육환경은 낙엽이 많으며 반그늘 혹은 음지에서 자생한다. 키는 30~100㎝이고, 잎은 길이가 3~10㎝, 폭이 1~6㎝로 광택이 나는 긴 잎자루를 가지고 있다. 2~3회 정도 깃털과 같은 모양으로 갈라지는 깃꼴겹잎으로, 끝이 뾰족하고 가장자리에 파고드는 모양의 톱니가 있다. 꽃은 흰색으로, 길이는 10~30㎝이며 부채꽃 모양으로 펼쳐지고 아래에서부터 피어서 위로 올라간다. 열매는 7~8월에 익고 갈색으로 타원형이며 길이가 약 0.3㎝가량인데, 익을 때는 광채가 있다. 관상용으로 쓰이며, 어린순은 식용으로 쓰인다. 본 발명에 특별히 지칭 또는 한정한 사항이 없는 경우 상기 눈개승마는 눈개승마의 어린순을 지칭하는 것으로 이해될 수 있다. 다만, 본 발명에 따른 눈개승마를 이에 한정하는 것은 아니다.The above snowgae horseback riding is a perennial herb that grows in alpine areas throughout the country. The growing environment is deciduous and grows wild in semi-shade or shaded areas. It is 30~100cm tall, and the leaves are 3~10cm long and 1~6cm wide and have long glossy petioles. It is a pinnate compound leaf that splits like a feather about 2 or 3 times, and has a sharp tip and a sawtooth in the shape of digging into the edge. The flowers are white, 10~30cm long, spread out in the shape of a fan, bloom from the bottom and go up. The fruits ripen in July-August, are brown, oval, and about 0.3 cm long, and have a brilliance when ripe. It is used as an ornamental, and the young shoots are used for food. If there is no particular designation or limitation in the present invention, it can be understood that the nungae riding horse refers to the young shoots of the nungae riding horse. However, the riding horse according to the present invention is not limited thereto.
본 명세서에서 사용되는 용어 "추출물"은 상술한 바와 같이 당업계에서 조추출물(crude extract)로 통용되는 의미를 갖지만, 광의적으로는 추출물을 추가적으로 분획(fractionation)한 분획물도 포함한다. 즉, 눈개승마 추출물은 상술한 추출용매를 이용하여 수득한 것뿐만 아니라, 여기에 정제과정을 추가적으로 적용하여 얻은 것도 포함한다. 예컨대, 상기 추출물을 일정한 분자량 컷-오프 값을 갖는 한외 여과막을 통과시켜 얻은 분획, 다양한 크로마토그래피(크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 분획도 본 발명의 눈개승마 추출물에 포함되는 것이다.As used herein, the term "extract" has the meaning commonly used as a crude extract in the art as described above, but in a broad sense also includes a fraction obtained by additionally fractionating the extract. That is, the extract of nipae equestrian horse includes not only those obtained using the above-described extraction solvent, but also those obtained by additionally applying a purification process here. For example, a fraction obtained by passing the extract through an ultrafiltration membrane having a constant molecular weight cut-off value, separation by various chromatography (prepared for separation according to size, charge, hydrophobicity or affinity), etc. The fraction obtained through the purification method is also included in the extract of the present invention.
상기 눈개승마 추출물은 기억력 및 인지기능을 개선하는 효과를 달성할 수 있다. 눈개승마에 포함된 유효성분의 활성으로 기억력 및 인지기능이 개선되어 건망증 등의 기억력 감퇴에 따른 질환을 예방 또는 개선할 수 있고, 수험생 등에 대한 학습능력을 증진할 수 있는 효과를 낼 수 있다.The snow gae equestrian extract can achieve the effect of improving memory and cognitive function. Memory and cognitive function are improved by the activity of the active ingredients contained in nungae horseback riding, so it is possible to prevent or improve diseases caused by memory loss such as forgetfulness, and it can have the effect of enhancing the learning ability for examinees, etc.
상기 기억력 및 인지기능 개선용 조성물은 연꽃 추출물 또는 두릅 추출물을 더 포함하는 것일 수 있다. 또는 상기 기억력 및 인지기능 개선용 조성물은 노니 추출물을 포함하는 것일 수 있다. 또한 바람직하게 상기 기억력 및 인지기능 개선용 조성물은 차즈기 추출물을 더 포함하는 것일 수 있다. 상기 범위에 의하는 경우 상호작용에 의한 상승효과로 기억력 및 인지기능 개선 활성이 높아질 수 있다. 또한 필요에 따라 원지, 구엽초, 석창포 등의 더 포함할 수 있다. The composition for improving memory and cognitive function may further include a lotus flower extract or an oleifera extract. Alternatively, the composition for improving memory and cognitive function may include a noni extract. Also preferably, the composition for improving memory and cognitive function may further include a chazugi extract. In the case of the above range, memory and cognitive function improvement activity may be increased due to a synergistic effect by interaction. In addition, it may further include raw paper, guyeopcho, seokchangpo, etc. as needed.
한편 본 발명에 따른 기억력 및 인지기능개선용 조성물은 눈개승마 추출물에 대하여 연꽃 추출물; 두릅 추출물; 노니 추출물; 차즈기 추출물이 포함되는 것일 수 있다, 상기 조합에 의하는 경우 각 추출물의 상호 작용에 의한 상승효과에 따라 기억력 및 인지기능개선 활성이 증진될 수 있다. 특히 다른 식물 추출물의 혼합의 경우에는 나타나지 않는 특유한 상승효과를 확인할 수 있다.On the other hand, the composition for improving memory and cognitive function according to the present invention is a lotus extract; elm extract; noni extract; Chazugi extract may be included. In the case of the above combination, the activity of improving memory and cognitive function may be enhanced according to the synergistic effect by the interaction of each extract. In particular, a unique synergistic effect that does not appear in the case of mixing of other plant extracts can be confirmed.
더 바람직하게 상기 기억력 및 인지기능 개선용 조성물은 상기 눈개승마 추출물 100 중량부에 대하여 연꽃 추출물 1 내지 5 중량부, 두릅 추출물 10 내지 30 중량부; 노니 추출물 1 내지 5 중량부 및 차즈기 추출물 5 내지 15 중량부를 더 포함하는 것일 수 있다.More preferably, the composition for improving memory and cognitive function includes: 1 to 5 parts by weight of lotus extract, 10 to 30 parts by weight of extract of oleracea; 1 to 5 parts by weight of the noni extract and 5 to 15 parts by weight of the chazugi extract may be further included.
상기 범위에 의하는 경우 기억력 및 인지기능개선 활성이 매우 우수할 수 있다. 특히 다른 추출물의 혼합 또는 다른 혼합범위에서는 찾아볼 수 없는 우수한 기억력 및 인지기능개선활성을 나타낼 수 있다.In the case of the above range, the activity of improving memory and cognitive function may be very excellent. In particular, it can exhibit excellent memory and cognitive function improvement activity that cannot be found in a mixture of other extracts or other mixing ranges.
상기 기억력 및 인지기능 개선용 조성물에 있어서, 상기 추출물은 물, 탄소수 1 내지 10의 알코올 및 이들의 혼합물로 이루어진 군에서 선택된 어느 하나를 용매로 추출된 것일 수 있다.In the composition for improving memory and cognitive function, the extract may be one selected from the group consisting of water, alcohols having 1 to 10 carbon atoms, and mixtures thereof with a solvent.
바람직하게 상기 용매는 물일 수 있다. 물을 용매로 눈개승마 추출물을 제조하는 경우 유효물질 수득에 유리할 수 있다.Preferably, the solvent may be water. When water is used as a solvent to prepare the extract of nevi horseradish, it may be advantageous to obtain an effective substance.
본 발명의 다른 일 실시예에 따른 기억력 개선 및 학습능력 증진용 식품은 상기 조성물을 포함하는 것일 수 있다.Food for improving memory and learning ability according to another embodiment of the present invention may include the composition.
구체적인 예로, 상기 식품 조성물을 이용하여 항균, 항염, 항바이러스 및 면역 기능 개선 효과를 증강시킬 수 있는 가공식품을 제조할 수 있다. 이런 가공식품에는 예를 들어, 과자, 차, 음료, 주류, 발효식품, 통조림, 우유가공식품, 육류가공식품, 국수 등을 포함한다. 과자는 비스킷, 파이, 케익, 빵, 캔디, 젤리, 껌, 시리얼등을 포함한다. 음료는 음용수, 탄산음료, 기능성 이온음료, 기능성이온음료, 주스(예를들어, 사과, 배, 포도, 알로에, 감귤, 복숭아, 당근, 토마토 쥬스 등), 식혜 등을 포함한다. 주류는 청주, 위스키, 소주, 맥주, 양주, 과실주 등을 포함한다. 발효식품은 간장, 된장, 고추장 등을 포함한다. 통조림은 수산물 통조림(예들 들어, 참치, 고등어, 꽁치, 소라 통조림 등), 축산물 통조림(쇠고기, 돼지고기, 닭고기, 칠면조 통조림 등), 농산물 통조림(옥수수, 복숭아, 파일애플 통조림 등)을 포함한다. 우유가공식품은 치즈, 버터, 요구르트 등을 포함한다. 육류가공식품은 돈까스, 비프까스, 치킨까스, 소세지. 탕수육, 너겟류, 너비아니 등을 포함한다. 밀봉포장생면 등의 국수를 포함한다. 이 외에도 상기 조성물은 레토르트식품, 스프류 등에 사용될 수 있다.As a specific example, by using the food composition, it is possible to prepare a processed food capable of enhancing the antibacterial, anti-inflammatory, antiviral and immune function improvement effects. Such processed foods include, for example, sweets, tea, beverages, alcoholic beverages, fermented foods, canned foods, milk products, processed meat foods, noodles, and the like. Confectionery includes biscuits, pies, cakes, breads, candies, jellies, gums, cereals, and the like. The beverage includes drinking water, carbonated beverage, functional ionized beverage, functional ionized beverage, juice (eg, apple, pear, grape, aloe, tangerine, peach, carrot, tomato juice, etc.), sikhye, and the like. Alcoholic beverages include sake, whiskey, shochu, beer, Western liquor, fruit wine, and the like. Fermented foods include soy sauce, soybean paste, red pepper paste, and the like. Canned foods include canned seafood (eg, canned tuna, mackerel, saury, conch, etc.), canned livestock products (canned beef, pork, chicken, turkey, etc.), and canned agricultural products (canned corn, peaches, file apples, etc.). Milk products include cheese, butter, yogurt, and the like. Processed meat products include pork cutlet, beef cutlet, chicken cutlet, and sausage. Includes sweet and sour pork, nuggets, and breadcrumbs. Noodles such as sealed packaged raw noodles are included. In addition to this, the composition may be used in retort foods, soups, and the like.
상기 식품은 오미자 추출물, 딸기 추출물, 아사이베리 추출물, 아로니아 추출물, 블루베리 추출물, 크랜베리 추출물, 자몽 추출물, 오렌지 추출물, 레몬 추출물, 초코민트 추출물, 바질 추출물, 페퍼민트 추출물, 세이지 추출물, 라벤더 추출물, 파슬리 추출물, 곰피 추출물, 방풍나물 추출물, 머위 추출물, 달래 추출물, 노니 추출물 및 이들의 혼합으로 이루어진 군에서 선택된 어느 하나를 더 포함하는 것일 수 있다.The food is Schisandra extract, strawberry extract, acai berry extract, aronia extract, blueberry extract, cranberry extract, grapefruit extract, orange extract, lemon extract, chocomint extract, basil extract, peppermint extract, sage extract, lavender extract, parsley It may be to further include any one selected from the group consisting of extracts, gompi extract, beetroot extract, coltsfoot extract, soothing extract, noni extract, and mixtures thereof.
상기 식품은 일반 식품, 가공식품, 건강기능식품, 기능성 식품을 포함하는 것으로 하며, 예시적으로 상기 식품에 대한 제형으로는 음료, 차, 정제, 육류가공식품, 스낵, 인스턴트식품 등으로 적용될 수 있다.The food shall include general food, processed food, health functional food, and functional food, and for example, the formulation for the food may be applied to beverages, tea, tablets, processed meat food, snacks, instant food, etc. .
본 발명의 또 다른 일 실시예에 따른 기억력 개선 및 학습능력 증진용 건강기능식품은 상기 조성물을 포함하는 것일 수 있다.A health functional food for improving memory and learning ability according to another embodiment of the present invention may include the composition.
상기 건강기능식품은 오미자 추출물, 딸기 추출물, 아사이베리 추출물, 아로니아 추출물, 블루베리 추출물, 크랜베리 추출물, 자몽 추출물, 오렌지 추출물, 레몬 추출물, 초코민트 추출물, 바질 추출물, 페퍼민트 추출물, 세이지 추출물, 라벤더 추출물, 파슬리 추출물, 곰피 추출물, 방풍나물 추출물, 머위 추출물, 달래 추출물 및 이들의 혼합으로 이루어진 군에서 선택된 어느 하나를 더 포함하는 것일 수 있다.The health functional food is Schisandra extract, strawberry extract, acai berry extract, aronia extract, blueberry extract, cranberry extract, grapefruit extract, orange extract, lemon extract, chocomint extract, basil extract, peppermint extract, sage extract, lavender extract , parsley extract, gompi extract, beetroot extract, coltsfoot extract, soothing extract, and any one selected from the group consisting of a mixture thereof may be further included.
바람직하게 상기 식품 또는 건강기능식품은 눈개승마 추출물 100 중량부에 대하여 오미자 0.1 내지 1 중량부; 크랜베리 추출물 0.1 내지 1 중량부; 페퍼민트 추출물 0.1 내지 2 중량부, 파슬리 추출물 1 내지 3 중량부 및 달래 추출물 0.1 내지 1 중량부를 더 포함하는 것일 수 있다. 상기 범위에 의하는 경우 눈개승마 추출물이 가진 기호성 낮은 향과 맛이 중화되면서 상당히 깊고 상큼한 향과 함께 기호성을 가진 식감의 식품 조성물로 제공할 수 있다. 특히 상기 범위에 의하는 경우 눈개승마 추출물에 비하여 10 중량% 미만으로 포함되는 것으로서, 눈개승마 추출물의 기능성을 해하지 않으면서도 상술한 바와 같이 눈개승마 추출물의 맛과 향미를 개선하여 상당히 기호성 높은 식품 조성물로 제공하게 할 수 있다. 또한 상술한 곰피 추출물; 방풍나물 추출물 및 차즈기 추출물을 더 하는 경우에도 맛과 향이 우수하여 기호성이 높고, 본 발명에서 목적하는 유효성분의 활성을 최대한 유지하게 할 수 있다는 장점을 가진다.Preferably, the food or health functional food is 0.1 to 1 part by weight of Omija based on 100 parts by weight of the extract of Nungae equestrian horse; 0.1 to 1 part by weight of cranberry extract; It may further include 0.1 to 2 parts by weight of peppermint extract, 1-3 parts by weight of parsley extract, and 0.1 to 1 parts by weight of soothing extract. According to the above range, it can be provided as a food composition with a palatable texture with a fairly deep and refreshing flavor while neutralizing the low palatability and taste of the extract of nipae extract. In particular, when according to the above range, it is included in less than 10% by weight compared to the nipae equestrian extract, and improves the taste and flavor of the nipae equestrian extract as described above without compromising the functionality of the nipae equestrian extract, making it a highly palatable food composition can provide In addition, the above-mentioned gompi extract; Even in the case of adding a persimmon leaf extract and chazugi extract, the taste and flavor are excellent, so the palatability is high, and it has the advantage that the activity of the active ingredient desired in the present invention can be maintained as much as possible.
상기 건강기능식품은 인지기능 또는 기억능력을 개선하거나 관련 질환을 건망증 등 기억력 및 인지기능 관련 질환을 예방하기 위하여 섭취할 수 있는 것이면 특별히 제한되지 않는다.The health functional food is not particularly limited as long as it can be ingested to improve cognitive function or memory ability, or to prevent related diseases such as memory and cognitive function related diseases such as forgetfulness.
본 발명의 건강기능식품 조성물을 식품첨가물로 사용하는 경우, 상기 건강기능식품 조성물을 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분은 그의 사용 목적(예방 또는 개선)에 따라 적절하게 사용될 수 있다. 일반적으로, 식품 또는 음료의 제조시 본 발명의 건강기능식품 조성물은 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양으로 첨가된다. 그러나 건강을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로 사용될 수 있다.When the health functional food composition of the present invention is used as a food additive, the health functional food composition may be added as it is or used together with other foods or food ingredients, and may be appropriately used according to a conventional method. The active ingredient may be used appropriately depending on the purpose of its use (prevention or improvement). In general, in the production of food or beverage, the health functional food composition of the present invention is added in an amount of 15 parts by weight or less, preferably 10 parts by weight or less, based on the raw material. However, in the case of long-term intake for health purposes, the amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount above the above range.
상기 건강기능식품의 종류에 특별한 제한은 없다. 본 발명의 건강기능식품 조성물은 식품, 특히 기능성 식품으로 제조될 수 있다. 본 발명의 기능성 식품은There is no particular limitation on the type of the health functional food. The health functional food composition of the present invention may be prepared as a food, particularly a functional food. The functional food of the present invention is
식품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 천연 탄수화물 또는 향미제를 추가 성분으로서 포함시킬 수 있다. 상기 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등),디사카라이드(예컨대, 말토스, 수크로오스 등), 올리고당, 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등) 또는 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)인 것이 바람직하다. 상기 향미제는 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등)와 합성 향미제(예컨대, 사카린, 아스파르탐 등)를 이용할 수 있다.It includes ingredients commonly added during food production, and includes, for example, proteins, carbohydrates, fats, nutrients and seasonings. For example, when manufactured as a drink, natural carbohydrates or flavoring agents may be included as additional ingredients in addition to the active ingredient. The natural carbohydrates include monosaccharides (eg, glucose, fructose, etc.), disaccharides (eg, maltose, sucrose, etc.), oligosaccharides, polysaccharides (eg, dextrin, cyclodextrin, etc.) or sugar alcohols (eg, , xylitol, sorbitol, erythritol, etc.) is preferable. As the flavoring agent, natural flavoring agents (eg, taumatine, stevia extract, etc.) and synthetic flavoring agents (eg, saccharin, aspartame, etc.) may be used.
상기 건강기능식품 조성물 이외에 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다.In addition to the health functional food composition, various nutrients, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, carbonic acid It may further contain a carbonation agent and the like used in beverages.
본 발명은 천연물을 기반으로 한 기억력 및 인지기능 개선효과를 가지는 눈개승마 추출물을 포함하는 조성물을 제공한다.The present invention provides a composition comprising an extract of naengae horseback riding having an effect of improving memory and cognitive function based on a natural product.
본 발명에 따른 눈개승마 추출물을 포함하는 조성물은 천연 추출물로서, 세포독성 등의 부작용의 문제가 없어 장기간 사용하면서, 기억력 및 인지기능 개선하고 학습능력을 증진할 수 있는 효과를 달성할 수 있다.The composition comprising the extract of nipae equestrian according to the present invention is a natural extract, and there is no problem of side effects such as cytotoxicity, so that it can be used for a long period of time, and can achieve the effect of improving memory and cognitive function and enhancing learning ability.
본 발명은 눈개승마 추출물을 포함하는 기억력 및 인지기능 개선할 수 있는 다양한 제형의 식품 또는 건강기능식품을 제공한다.The present invention provides foods or health functional foods of various formulations that can improve memory and cognitive function, including the extract of nipae equestrian horse.
본 발명은 상기 눈개승마에 대한 새로운 용도를 제시하고, 이를 통하여 다양한 기능성 제품으로 상품화 됨으로서, 상기 눈개승마에 대한 새로운 수요가 발굴될 수 있도록 한다.The present invention proposes a new use for the snow horse riding, and through this, it is commercialized into various functional products, so that a new demand for the snow horse riding can be discovered.
이하, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시예에 대하여 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다.Hereinafter, embodiments of the present invention will be described in detail so that those of ordinary skill in the art can easily carry out the present invention. However, the present invention may be embodied in several different forms and is not limited to the embodiments described herein.
[제조예: 눈개승마 추출물의 제조][Preparation Example: Preparation of Snow Gaeseosaurus Extract]
1. 눈개승마 추출물의 제조1. Manufacture of snow horse equestrian extract
눈개승마 어린순을 세척 및 건조하고, 분쇄한 뒤 열수 추출하고, 농축 여과하여 눈개승마 추출물(KJB)을 제조하였다. 상기 눈개승마 추출물을 일정한 농도로 희석하면서 이하의 실험을 진행하였다.After washing and drying young shoots, pulverized, hot water extraction, and concentrated filtration were performed to prepare an extract of nevi horseradish (KJB). The following experiment was carried out while diluting the nurigae equestrian extract to a certain concentration.
2. 혼합 추출물의 제조2. Preparation of Mixed Extracts
상기와 KJB과 동일한 방법에 따라 열수추출을 통하여, 연꽃 추출물(AD1); 두릅 추출물(AD2); 노니 추출물(AD3), 차즈기 추출물(AD4), 오미자 추출물(E1), 크랜베리 추출물(E2), 페퍼민트 추출물(E3), 파슬리 추출물(E4) 및 달래 추출물(E5)를 제조하고 각 추출물을 하기의 [표 1]과 같은 조성에 따라 혼합 조성을 제조하였다.Through hot water extraction according to the same method as above and KJB, lotus flower extract (AD1); elm extract (AD2); Noni extract (AD3), Chazugi extract (AD4), Schisandra extract (E1), cranberry extract (E2), peppermint extract (E3), parsley extract (E4) and soothing extract (E5) were prepared, and each extract was prepared as follows. A mixed composition was prepared according to the composition shown in [Table 1].
(단위: 중량부)(Unit: parts by weight)
[실험예 1: 기억력 및 인지기능 개선 효과 실험][Experimental Example 1: Memory and cognitive function improvement effect experiment]
1. DPPH radical 분석1. DPPH radical analysis
생체에서 산화적 스트레스와 관련되어 있는 DPPH, superoxide anion과 같은 활성산소종에 대한 분석을 위하여 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical을 이용하여 KJB 및 M1 내지 M5의 radical 소거능력을 측정하였다. KJB 및 M1 내지 M5에 DPPH 용액을 가하여 반응시킨 후 흡광도를 측정하였다. DPPH radical 함량은 시료 첨가군과 대조군의 흡광도 비를 %값으로 환산하여 [표 2]에 나타내었다.For the analysis of reactive oxygen species such as DPPH and superoxide anion related to oxidative stress in vivo, the radical scavenging ability of KJB and M1 to M5 was measured using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical. did After reacting by adding a DPPH solution to KJB and M1 to M5, absorbance was measured. The DPPH radical content is shown in [Table 2] by converting the absorbance ratio of the sample addition group and the control group to a % value.
2. 환원력 분석2. Reducing Power Analysis
Superoxide anion 라디칼 소거능은 Fridovich법에 따라 진행하였다. 시료 1 ml에 pH 6.6의 200 mM 인산 완충액 및 potassium ferricyanide를 각각 1 ml씩 차례로 가하여 반응시켰다. 여기에 10% TCA (trichloroacetic acid)용액을 상등액에 증류수 및 ferric chloride 혼합한 후 흡광도를 측정하였다. KJB 및 M1 내지 M5은 대조군의 값을 기준으로 흡광도 비를 %값으로 환산하여 하기의 [표 3]에 나타내었다.Superoxide anion radical scavenging activity was performed according to the Fridovich method. To 1 ml of the sample, 200 mM phosphate buffer at pH 6.6 and 1 ml of potassium ferricyanide were sequentially added and reacted. Here, 10% TCA (trichloroacetic acid) solution was mixed with distilled water and ferric chloride in the supernatant, and absorbance was measured. KJB and M1 to M5 are shown in [Table 3] below by converting the absorbance ratio into % value based on the value of the control group.
3. Hydroxyl radical에 의한 DNA 손상 분석3. Analysis of DNA damage by hydroxyl radical
Genomic DNA는 약간 변형된 표준 과정에 따라 PC12 세포로부터 추출하였다. DNA 용액에 KJB 및 M1 내지 M5와 200 μM FeSO4, 1 mM H2O2 및 50 μg/ml genomic DNA를 첨가하였다. 반응 종결 후 전기영동 하였다. 염색하여 후 UV로 LAS3000 image analyzer를 이용하여 관찰하였고, 무처리군을 기준으로 그 결과를 %화 하여 하기의 [표 4]에 나타내었고, 그 % 수치가 낮을수록 우수한 것이다.Genomic DNA was extracted from PC12 cells according to a slightly modified standard procedure. To the DNA solution, KJB and M1 to M5, 200 μM FeSO4, 1 mM H2O2, and 50 μg/ml genomic DNA were added. After completion of the reaction, electrophoresis was performed. After dyeing, it was observed using a LAS3000 image analyzer with UV light, and the results were expressed in % based on the untreated group and shown in [Table 4] below, and the lower the % value, the better.
4. ACE (Angiotensin I Converting Enzyme) 활성 측정4. Measurement of Angiotensin I Converting Enzyme (ACE) Activity
ACE 활성은 KJB 및 M1 내지 M5에 각각 붕산나트륨 완충액(pH 8.3)과 ACE 조효소액 가하여 예비반응을 진행한 후 시킨 후, HHL(hippuryl-histidyl-leucine)을 첨가하여 만든 기질을 가하여 반응하였다. 한편, ACE 조효소액은 sodium borate buffer (pH 8.3)에 rabbit lung acetone powder을 추출한 다음 원심분리하여 제조하였다. 반응 후 채취한 상등액을 건조 및 증류수를 혼합하고 흡광도를 측정하였다. 음성대조군으로는 증류수를 사용하였으며, 무처리군을 기준(100%)으로 시료 첨가 전후의 흡광도 비를 %값으로 환산하여 하기의 [표 5]에 나타내었다.ACE activity was pre-reacted by adding sodium borate buffer (pH 8.3) and ACE coenzyme to KJB and M1 to M5, respectively, and then reacted by adding a substrate prepared by adding HHL (hippuryl-histidyl-leucine). Meanwhile, the ACE coenzyme solution was prepared by extracting rabbit lung acetone powder in sodium borate buffer (pH 8.3) and then centrifuging. The supernatant collected after the reaction was mixed with dried and distilled water, and absorbance was measured. Distilled water was used as a negative control group, and the absorbance ratio before and after addition of the sample was converted into % values based on the untreated group as a standard (100%), and is shown in [Table 5] below.
5. AChE (Acetylcholine esterase) 활성측정5. AChE (Acetylcholine esterase) activity measurement
PC12 세포로부터 분리한 AchE (25 mU/ml) 50μl를 반응효소로, 0.1 M의 인산나트륨 완충액(pH 7.8)에 녹인 아세틸콜린 요오드화물을 기질로 하였고, 발색 시약은 5,5'-dithiobis-2-nitrobenzoic acid 및 탄산수소나트륨을 0.1 M 인산나트륨 완충액(pH 7.0) 10 ml에 용해하여 제조하였다. 반응 후, 분광광도계로 412 nm에서 흡광도 값을 측정하였다. AChE의 활성은 무처리군을 기준(100%)으로 KJB 및 M1 내지 M5의 첨가 전후의 흡광도 비를 %값으로 환산하여 하기의 [표 6]에 나타내었다.50 μl of AchE (25 mU/ml) isolated from PC12 cells was used as a reaction enzyme, and acetylcholine iodide dissolved in 0.1 M sodium phosphate buffer (pH 7.8) was used as a substrate, and the chromogenic reagent was 5,5'-dithiobis-2 -nitrobenzoic acid and sodium hydrogen carbonate were dissolved in 10 ml of 0.1 M sodium phosphate buffer (pH 7.0). After the reaction, the absorbance value was measured at 412 nm with a spectrophotometer. The activity of AChE is shown in [Table 6] below by converting the absorbance ratio before and after the addition of KJB and M1 to M5 into % values based on the untreated group (100%).
6. C12세포에서 NF-κB 전사활성에 대한 시험6. Test for NF-κB transcriptional activity in C12 cells
PC12 cells을 배양하면서 NF-κB promoter-luciferase construct를 이용하여 NF-κB의 전사 활성을 평가하여 KJB 및 M1 내지 M5에 대한 C12세포에서 NF-κB 전사활성에 대한 영향을 비교하였다. KJB의 결과를 10로 고정하고, M1 내지 M5의 결과를 상대지수로 평가하여 [표 7]에 나타내었다. 상기 지수가 높을수록 NF-κB의 전사 활성이 우수한 것이다.While culturing PC12 cells, the transcriptional activity of NF-κB was evaluated using the NF-κB promoter-luciferase construct, and the effect on NF-κB transcriptional activity in C12 cells for KJB and M1 to M5 was compared. The results of KJB were fixed at 10, and the results of M1 to M5 were evaluated as relative indices, and are shown in [Table 7]. The higher the index, the better the transcriptional activity of NF-κB.
결국 본 발명에 의하는 경우 활성산소종의 제거, DNA 손상에 대한 항산화, ACE(Angiotensin Converting Enzyme) 효소 저해활성, AChE(acetylcholine esterase) 저해 활성, NO(Nitric oxide) 생성 억제활성, NF-κB 전사활성 증가효과가 나타난다는 점을 확인할 수 있다. 또한 M2 내지 M4의 혼합조성에 의하는 경우 일정한 상승효과가 나타나는 점을 알 수 있다.In the end, according to the present invention, removal of reactive oxygen species, antioxidant against DNA damage, ACE (Angiotensin Converting Enzyme) enzyme inhibitory activity, AChE (acetylcholine esterase) inhibitory activity, NO (nitric oxide) production inhibitory activity, NF-κB transcription It can be seen that the activity increasing effect appears. In addition, it can be seen that a certain synergistic effect appears in the case of the mixed composition of M2 to M4.
따라서 상기 눈개승마 추출물 또는 눈개승마 추출물에 대한 혼합구성을 기초로, 기억력 및 두뇌 인지기능 개선을 위한 효과를 낼 수 있는 다양한 제품에 적용시킬 수 있다.Therefore, it can be applied to a variety of products that can produce effects for improving memory and brain cognitive function based on the mixed composition of the nipae equestrian extract or the nipae equestrian extract.
7, 일반 육상미로 실험7, general land maze experiment
2주간 일정한 크기로 제작된 방사형 미로의 통로를 마우스에게 학습시킨 뒤, 해당 마우스에 대하여 4일 동안 M1 내지 M5를 하루에 3차례씩 복용시킨 뒤 준비된 미로를 통과하는데 소요되는 시간을 3차례 측정하였다. 대조군으로는 정제수를 섭취한 군을 사용하였으며, 상기 대조군의 시간 결과와 대비하여 1 내지 10의 지수로 평가하였다. 한편, 상기 지수는 그 숫자가 높을수록 효과가 우수한 것이다.After learning the passage of the radial maze made of a constant size for 2 weeks, the mice were given M1 to M5 3 times a day for 4 days, and then the time required to pass through the prepared maze was measured 3 times. . As a control group, a group ingesting purified water was used, and it was evaluated as an index of 1 to 10 compared to the time result of the control group. On the other hand, the higher the number of the index, the better the effect.
하기의 [표 8]에 그 결과를 나타내었다.The results are shown in [Table 8] below.
(단위: 지수)(Unit: Index)
상기 [표 8]을 참조하면, KJB 및 혼합제형 M1 내지 M5의 경우 기억력 증진 효과가 나타나는 점을 확인할 수 있다. 특히 M2 및 M4의 경우 각 조성물의 상호 조합에 따른 상승효과로 기억력 개선활성이 크게 높아지는 점을 알 수 있다. 이를 통하여 상기 M2 및 M4의 함량범위에 의하는 경우 적은 함량으로 세포독성 등 부작용의 문제없이 장기간 복용하면서 기억력 개선활성을 증진할 수 있는 조성물로 제공할 수 있다는 점을 확인할 수 있다.Referring to [Table 8], in the case of KJB and the mixed formulations M1 to M5, it can be seen that the memory enhancing effect appears. In particular, in the case of M2 and M4, it can be seen that the memory improving activity is greatly increased due to the synergistic effect according to the mutual combination of each composition. Through this, it can be confirmed that, according to the content range of M2 and M4, it is possible to provide a composition capable of enhancing memory-improving activity while taking it for a long time without problems of side effects such as cytotoxicity with a small content.
[실험예 2: 기호성 평가][Experimental Example 2: Evaluation of palatability]
KJB 및 상기 T1 내지 T5의 조성에 따라 차 음료를 제조하고, 10인의 시험자에게 시음하게 한 뒤 향과 맛을 평가하게 하여 1 내지 10의 기호도를 평가하도록 하였다. 그 결과를 종합하여 평균한 뒤 하기의 [표 9]에 나타내었다. 하기의 지수는 그 숫자가 높을 수록 기호도가 우수한 것이다(각 지수는 평균 값에 반올림을 적용하였다).A tea beverage was prepared according to the composition of KJB and T1 to T5, and after tasting it, 10 testers were asked to evaluate the flavor and taste to evaluate the preference of 1 to 10. The results are summarized and averaged and shown in [Table 9] below. In the following indices, the higher the number, the better the preference (rounding is applied to the average value for each index).
(단위: 지수)(Unit: Index)
상기 기호성 평가 결과를 참조하면, 대부분의 시음자들이 눈개승마 자체와 달리 눈개승마 추출물은 씁쓸하고 강한 향 때문에 전반적인 기호성 평가에서 낮은 평가 점수가 나타난다는 점을 확인하였다. 다만, T2 및 T3의 혼합조성에 의하는 경우 전체적으로 달고 달큰한 향과 눈개승마 고유의 향미 중화되어 은은하게 느껴지면서 전체적으로 맛과 향이 우수하게 되는 점을 확인할 수 있었다. Referring to the palatability evaluation result, it was confirmed that most of the tasters showed a low evaluation score in the overall palatability evaluation because of the bitter and strong scent of the nungae equestrian extract unlike the nungae equestrian horse itself. However, in the case of the mixed composition of T2 and T3, it was confirmed that the overall taste and flavor were excellent while the overall sweet and sweet scent and the unique flavor of Nonigaeseungma were neutralized, so that it felt soft.
특히 T5를 참조하면 상기 혼합 조성에 의하는 경우 E1 내지 E5의 혼합물이 눈개승마 추출물에 대하여 10 중량% 미만으로 포함되기 때문에 눈개승마의 유효성분에 따른 활성을 최대한 유지하면서도 기호성이 우수할 수 있다. 또한 상기 조성에 의하는 경우 M3에 대한 조성에 있어서도 기호성을 향상시키는 효과를 낼 수 있다는 점을 알 수 있다.In particular, referring to T5, according to the mixed composition, since the mixture of E1 to E5 is contained in an amount of less than 10% by weight based on the extract of nipae equestrian horse, the palatability can be excellent while maintaining the activity according to the active ingredient of nipae equestrian horse as much as possible. In addition, it can be seen that, in the case of the above composition, the effect of improving palatability can be achieved even in the composition for M3.
이상에서 본 발명의 바람직한 실시예에 대하여 상세하게 설명하였지만 본 발명의 권리범위는 이에 한정되는 것은 아니고 다음의 청구범위에서 정의하고 있는 본 발명의 기본 개념을 이용한 당업자의 여러 변형 및 개량 형태 또한 본 발명의 권리범위에 속하는 것이다.Although preferred embodiments of the present invention have been described in detail above, the scope of the present invention is not limited thereto, and various modifications and improvements by those skilled in the art using the basic concept of the present invention as defined in the following claims are also provided. is within the scope of the
Claims (5)
기억력 및 인지기능 개선용 조성물.Containing snow horse riding extract
A composition for improving memory and cognitive function.
상기 추출물은,
물, 탄소수 1 내지 10의 알코올 및 이들의 혼합물로 이루어진 군에서 선택된 어느 하나를 용매로 추출된 것인
기억력 및 인지기능 개선용 조성물.The method of claim 1,
The extract is
Any one selected from the group consisting of water, alcohols having 1 to 10 carbon atoms and mixtures thereof is extracted with a solvent
A composition for improving memory and cognitive function.
연꽃 추출물 또는 두릅 추출물을 더 포함하는 것인
기억력 및 인지기능 개선용 조성물.The method of claim 1,
Which further comprises a lotus flower extract or elm oleifera extract
A composition for improving memory and cognitive function.
노니 추출물을 더 포함하는 것인
허혈성 재관류 손상의 예방 및 개선용 조성물.4. The method of claim 3,
Which further comprises a noni extract
A composition for preventing and improving ischemic reperfusion injury.
기억력 개선 및 학습능력 증진용 식품.5. A composition comprising the composition according to any one of claims 1 to 4,
Food for improving memory and learning ability.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200154817A KR102488670B1 (en) | 2020-11-18 | 2020-11-18 | Composition for improving memory and learning ability including natural plant extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200154817A KR102488670B1 (en) | 2020-11-18 | 2020-11-18 | Composition for improving memory and learning ability including natural plant extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220067979A true KR20220067979A (en) | 2022-05-25 |
KR102488670B1 KR102488670B1 (en) | 2023-01-12 |
Family
ID=81797258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200154817A KR102488670B1 (en) | 2020-11-18 | 2020-11-18 | Composition for improving memory and learning ability including natural plant extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102488670B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040062273A (en) | 2003-01-02 | 2004-07-07 | 서울향료(주) | Composition comprising the extracts of Longanae arillus, Zizyphi spinosae semen, Polygalae radix and Poria cocos for the enhancement of memory and the prevention and treatment of dementia |
KR20100135083A (en) | 2009-06-16 | 2010-12-24 | 주식회사 제이비티 | Enhance learning ability health food |
KR20200027680A (en) * | 2018-09-05 | 2020-03-13 | 경상대학교산학협력단 | A method for preparing ethyl acetate fraction from Aruncus dioicus var. kamtschaticus and the composition comprising the same as the effective ingredient |
-
2020
- 2020-11-18 KR KR1020200154817A patent/KR102488670B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040062273A (en) | 2003-01-02 | 2004-07-07 | 서울향료(주) | Composition comprising the extracts of Longanae arillus, Zizyphi spinosae semen, Polygalae radix and Poria cocos for the enhancement of memory and the prevention and treatment of dementia |
KR20100135083A (en) | 2009-06-16 | 2010-12-24 | 주식회사 제이비티 | Enhance learning ability health food |
KR20200027680A (en) * | 2018-09-05 | 2020-03-13 | 경상대학교산학협력단 | A method for preparing ethyl acetate fraction from Aruncus dioicus var. kamtschaticus and the composition comprising the same as the effective ingredient |
Non-Patent Citations (4)
Title |
---|
Kwon et al., Chronic Alcohol Exposure Induced Neuroapoptosis: Diminishing Effect of Ethyl Acetate Fraction from Aralia elata. Hindawi Oxidative Medicine and Cellular Longevity. Volume 2019, Article ID 7849876, 15 pages 1부.* * |
Pachauri et al., Protective effect of fruits of Morinda citrifolia L. on scopolamine induced memory impairment in mice: A behavioral, biochemical and cerebral blood flow study. Journal of Ethnopharmacology. 2012, Vol. 139, pp. 34- 41 1부.* * |
Park et al., Effect of Aruncus dioicus var. kamtschaticus Extract on Neurodegeneration Improvement: Ameliorating Role in Cognitive Disorder Caused by High-Fat Diet Induced Obesity. Nutrients 2019, 1 * |
Yang et al., Novel effects of Nelumbo nucifera rhizome extract on memory and neurogenesis in the dentate gyrus of the rat hippocampus. Neuroscience Letters. 2008, Vol. 443, pp. 104-107 1부.* * |
Also Published As
Publication number | Publication date |
---|---|
KR102488670B1 (en) | 2023-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100375560B1 (en) | Composition comprising extract of Platycodon grandiflorusjacqin A De Candolle with anti-bronchus- disease activity | |
KR20010069022A (en) | Functional beverage containing water extract of Hovenia dulcis and process for preparation thereof | |
KR101246574B1 (en) | Manufacturing method for making high quality cherry wine with various varieties or enzyme treatment | |
CN104560576B (en) | Maca health preserving wine and preparation method thereof | |
KR101001361B1 (en) | Natural carbonated beverage comprising tea leaves and mulberries juice and a preparation method thereof | |
KR20120071932A (en) | Lactic acid fermented solution of wild plant with enhanced antioxidative and antihypertensive activity | |
KR102488670B1 (en) | Composition for improving memory and learning ability including natural plant extract | |
KR100543776B1 (en) | The preperation method of mulberrry liquor | |
KR100367551B1 (en) | Beverage of gorosae sap | |
KR20230138679A (en) | Composition for preventing or improving recognitive function disorder or memory disorder comprising fermented rhodiola sachalinesis | |
KR20160021643A (en) | Manufacturing Method of Beverage Using Extract from Aronia | |
KR102191500B1 (en) | A composition for improving memory and cognitive function, preventing and improving ischemia reperfusion injury including stachys sieboldii miq extract | |
JP2012006905A (en) | Composition for skin care | |
KR102100989B1 (en) | Method for producing inner beauty beverage using Chrysanthemum zawadskii and fermeted Rhus verniciflua | |
JPS60256374A (en) | Vinegar drink and production thereof | |
KR101948581B1 (en) | Compositions for improving or enhancing memory comprising extracts of puffed red ginseng, fruit of a chinese matrimony vine and cornus officinalis | |
KR20160069530A (en) | Method for producing Hovenia dulcis vinegar powder and Hovenia dulcis vinegar powder produced by the same method | |
CN104694354A (en) | Anti-fatigue health care wine and preparing method thereof | |
KR102296272B1 (en) | A composition for improving memory and cognitive function, preventing and improving ischemia reperfusion injury including acorus gramineus soland extract | |
Sarkar et al. | Development of health functional wine produced from Emblica officinalis and Phyllanthus niruri and a comparative study of them over commercial wine | |
KR102191452B1 (en) | A COMPOSITION FOR IMPROVING MEMORY AND COGNITIVE FUNCTION, PREVENTING AND IMPROVING ISCHEMIA REPERFUSION INJURY INCLUDING dried persimmon EXTRACT | |
KR102561961B1 (en) | Development of functional fermented Kombucha using various natural plant materials and use as food, medicine and cosmetic materials | |
CN109251825A (en) | Wilsonii ice red wine and preparation method thereof | |
AU2021102610A4 (en) | Compound black fermented fruit wine and method for preparing the same | |
KR102552886B1 (en) | Composition for preventing and improving obesity, and functional food containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |